You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Adalimumab for treating rheumatoid arthritis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2005
|
| DOI | 10.1002/14651858.cd005113.pub2 |
| Pubmed ID | |
| Authors |
Federico Navarro‐Sarabia, Rafael Ariza‐Ariza, Blanca Hernandez‐Cruz, Isidro Villanueva |
| Abstract |
Adalimumab is a fully human anti-TNFalpha monoclonal antibody. Published studies indicate that its use in patients with RA can be effective and safe. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Practitioners (doctors, other healthcare professionals) | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 1% |
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| Finland | 1 | <1% |
| United Kingdom | 1 | <1% |
| Sri Lanka | 1 | <1% |
| Unknown | 166 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 31 | 18% |
| Student > Master | 25 | 14% |
| Student > Ph. D. Student | 17 | 10% |
| Student > Bachelor | 16 | 9% |
| Student > Postgraduate | 11 | 6% |
| Other | 28 | 16% |
| Unknown | 45 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 68 | 39% |
| Nursing and Health Professions | 10 | 6% |
| Agricultural and Biological Sciences | 9 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Other | 18 | 10% |
| Unknown | 53 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2023.
All research outputs
#4,628,254
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#6,791
of 11,499 outputs
Outputs of similar age
#11,111
of 69,215 outputs
Outputs of similar age from Cochrane database of systematic reviews
#18
of 39 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,215 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.